BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 29881556)

  • 1. Hematopoietic cell transplantation for myeloid/NK cell precursor acute leukemia in second remission.
    Noguchi Y; Tomizawa D; Hiroki H; Miyamoto S; Tezuka M; Miyawaki R; Tanaka-Kubota M; Okano T; Kobayashi C; Mitsuiki N; Aoki Y; Imai K; Kajiwara M; Kanegane H; Morio T; Takagi M
    Clin Case Rep; 2018 Jun; 6(6):1023-1028. PubMed ID: 29881556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloid/natural killer (NK) cell precursor acute leukemia as a distinct leukemia type.
    Nishimura A; Yokoyama K; Naruto T; Yamagishi C; Imamura T; Nakazono H; Kimura S; Ito M; Sagisaka M; Tanaka Y; Piao J; Namikawa Y; Yanagimachi M; Isoda T; Kanai A; Matsui H; Isobe T; Sato-Otsubo A; Higuchi N; Takada A; Okuno H; Saito S; Karakawa S; Kobayashi S; Hasegawa D; Fujisaki H; Hasegawa D; Koike K; Koike T; Rai S; Umeda K; Sano H; Sekinaka Y; Ogawa A; Kinoshita A; Shiba N; Miki M; Kimura F; Nakayama H; Nakazawa Y; Taga T; Taki T; Adachi S; Manabe A; Koh K; Ishida Y; Takita J; Ishikawa F; Goto H; Morio T; Mizutani S; Tojo A; Takagi M
    Sci Adv; 2023 Dec; 9(50):eadj4407. PubMed ID: 38091391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five Chinese pediatric patients with leukemias possibly arising from immature natural killer cells: clinical features and courses.
    Guan XQ; Xu L; Ke ZY; Huang LB; Zhang XL; Zhang YC; Luo XQ
    Pediatr Hematol Oncol; 2011 Apr; 28(3):187-93. PubMed ID: 21271777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of a child with myeloid/NK cell precursor acute leukemia with L-asparaginase and unrelated cord blood transplantation.
    Tezuka K; Nakayama H; Honda K; Suzumiya J; Oshima K; Kitoh T; Ishii E
    Int J Hematol; 2002 Feb; 75(2):201-6. PubMed ID: 11939270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haploidentical Natural Killer Cells Infused before Allogeneic Stem Cell Transplantation for Myeloid Malignancies: A Phase I Trial.
    Lee DA; Denman CJ; Rondon G; Woodworth G; Chen J; Fisher T; Kaur I; Fernandez-Vina M; Cao K; Ciurea S; Shpall EJ; Champlin RE
    Biol Blood Marrow Transplant; 2016 Jul; 22(7):1290-1298. PubMed ID: 27090958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignancies of natural killer (NK) cell precursor: myeloid/NK cell precursor acute leukemia and blastic NK cell lymphoma/leukemia.
    Suzuki R; Nakamura S
    Leuk Res; 1999 Jul; 23(7):615-24. PubMed ID: 10400182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pralatrexate as a bridge to allogeneic hematopoietic stem cell transplantation in a patient with advanced-stage extranodal nasal-type natural killer/T cell lymphoma refractory to first-line chemotherapy: a case report.
    Liu YC; Lin TA; Wang HY; Ko PS; Liu CJ; Hsiao LT; Chien SH; Gau JP
    J Med Case Rep; 2020 Mar; 14(1):43. PubMed ID: 32183896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Successful treatment of myeloid/natural killer cell precursor acute leukemia with allogeneic peripheral blood stem cell transplantation].
    Shimokawa T; Saitoh M; Kojima Y; Takeyama H
    Rinsho Ketsueki; 2002 Feb; 43(2):112-6. PubMed ID: 11925873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Observation on the efficacy of consolidation chemotherapy combined with allogeneic natural killer cell infusion in the treatment of low and moderate risk acute myeloid leukemia].
    Wang CJ; Huang XJ; Gong LZ; Jia JS; Liu XH; Wang Y; Yan CH; Chang YJ; Zhao XS; Shi HX; Lai YY; Jiang H
    Zhonghua Xue Ye Xue Za Zhi; 2019 Oct; 40(10):812-817. PubMed ID: 31775478
    [No Abstract]   [Full Text] [Related]  

  • 10. [Acute leukemia recurring as extramedullary tumors of the ovary following allogeneic hematopoietic stem cell transplantation].
    Imanaka R; Katayama Y; Iwato K; Kyo K; Okatani T; Itagaki M; Katsutani S; Asaoku H
    Rinsho Ketsueki; 2018; 59(1):58-63. PubMed ID: 29415939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia: a distinct hematolymphoid disease entity.
    Suzuki R; Yamamoto K; Seto M; Kagami Y; Ogura M; Yatabe Y; Suchi T; Kodera Y; Morishima Y; Takahashi T; Saito H; Ueda R; Nakamura S
    Blood; 1997 Sep; 90(6):2417-28. PubMed ID: 9310493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloid/natural killer cell precursor acute leukemia with multiple subcutaneous nodules as the initial presentation: a case report and literature review.
    Ma Y; Chen B; Xu X; Lin G
    Int J Hematol; 2009 Sep; 90(2):243-247. PubMed ID: 19639272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haploidentical Natural Killer Cell Therapy as an Adjunct to Stem Cell Transplantation for Treatment of Refractory Acute Myeloid Leukemia.
    Kulkarni U; Arunachalam AK; Palani HK; Nair RR; Balasundaram N; Venkatraman A; Korula A; Selvarajan S; Lionel S; Balasubramanian P; Maddali M; Abraham A; George B; Mathews V
    Cell Transplant; 2023; 32():9636897231198178. PubMed ID: 37706453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A child with myeloid/natural killer cell precursor acute leukemia treated successfully with acute myeloid leukemia-oriented chemotherapy incorporating L-asparaginase.
    Morimoto M; Kondoh K; Keino D; Ohyama R; Ban S; Kinoshita A; Kitoh T
    Leuk Res; 2010 Dec; 34(12):1677-9. PubMed ID: 20637505
    [No Abstract]   [Full Text] [Related]  

  • 15. Secondary chronic myeloid leukemia following acute myeloid leukemia treated with autologous hematopoietic stem cell transplantation: a case report.
    Cheng J; Liao Y; Bin T; OUYang J; Chen S; Chen X; Zou W
    Curr Med Res Opin; 2020 Nov; 36(11):1807-1812. PubMed ID: 32936052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pediatric myeloid/NK cell precursor lymphoma/leukemia expressing T/NK immunophenotype markers.
    Hashii Y; Okuda T; Ohta H; Ozono K; Hara J
    Int J Hematol; 2010 Apr; 91(3):525-9. PubMed ID: 20146030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extramedullary presentation of acute leukaemia: a case of myeloid/natural killer cell precursor leukaemia.
    Chen VM; McIlroy K; Loui JP; Fay K; Ward C
    Pathology; 2003 Aug; 35(4):325-9. PubMed ID: 12959763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical Safety of NK Cell in the Prevention of Leukemia Relapse Post-transplantation and in Treatment of the Elderly Leukemia Patients].
    Liu J; Zheng XL; Xue M; Zhu L; Ding L; Han DM; Yan HM; Li S; Ma JD; Tan XT; Zhou JX; Guo ZK; Wang HX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Aug; 30(4):1267-1271. PubMed ID: 35981396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and management of natural killer-cell malignancies.
    Ishida F; Kwong YL
    Expert Rev Hematol; 2010 Oct; 3(5):593-602. PubMed ID: 21083476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor-Derived Natural Killer Cell Infusion after Human Leukocyte Antigen-Haploidentical Hematopoietic Cell Transplantation in Patients with Refractory Acute Leukemia.
    Choi I; Yoon SR; Park SY; Kim H; Jung SJ; Kang YL; Lee JH; Lee JH; Kim DY; Lee JL; Park HS; Choi EJ; Lee YS; Kang YA; Jeon M; Seol M; Baek S; Yun SC; Kim HJ; Lee KH
    Biol Blood Marrow Transplant; 2016 Nov; 22(11):2065-2076. PubMed ID: 27530969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.